Helmuth Reuter

Helmuth Reuter

Stellenbosch University - Stellenbosch / South Africa
Medical and Health Sciences / Rheumatology
AD Scientific Index ID: 98989
University of Stellenbosch
person_outline Helmuth Reuter's MOST POPULAR ARTICLES
1-) Alirocumab and cardiovascular outcomes after acute coronary syndromeGG Schwartz, PG Steg, M Szarek, DL BhattN Engl J Med 379 (22), 2097-2107, 201825372018
2-) Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid ArthritisSR Ytterberg, DL Bhatt, TR Mikuls, GG Koch, R Fleischmann, JL Rivas, ...New England Journal of Medicine 386 (4), 316-326, 20224162022
3-) Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase …R Fleischmann, E Mysler, S Hall, AJ Kivitz, RJ Moots, Z Luo, R DeMasi, ...Lancet 390 (10093), 457-68, 20174422017
4-) Baricitinib, methotrexate, or combination in patients with rheumatoid arthritis and no or limited prior disease‐modifying antirheumatic drug treatmentR Fleischmann, M Schiff, D van der Heijde, C Ramos‐Remus, A Spindler, ...Arthritis & Rheumatology 69 (3), 506-517, 20174442017
5-) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, OOC InvestigatorsLancet Diabetes Endocrinol. 7 (8), 618-628, 20192722019